Imricor Medical Completes First In Vivo Pulsed Field Ablation in Ventricle Under MRI Guidance

MT Newswires Live
10/20

Imricor Medical Systems (ASX:IMR) said it completed the first-ever pre-clinical animal study in vivo pulsed field ablation in the ventricle under real-time magnetic resonance imaging (MRI) guidance in an interventional cardiac magnetic resonance imaging laboratory, according to a Monday Australian bourse filing.

The procedure was performed using the firm's second-generation Vision-MR ablation catheter at its iCMR Design Center, validating its technology for integrating pulsed field ablation energy with real-time MRI visualization.

The firm's shares fell 1% in recent trading on Monday.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10